EpimAb Biotherapeutics
company
Funding Round
Series C
Money Raised
$ 120M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| MiraeAsset Financial Group | - | Yes | - | Detail |
| CMB International Capital Corporation | - | Yes | - | Detail |
| Hidragon Capital | - | - | - | Detail |
| Adrian Cheng | - | - | - | Detail |
| Cormorant Asset Management | - | - | - | Detail |
| Decheng Capital | - | - | - | Detail |
| Hony Capital | - | - | - | Detail |
| Octagon Capital Advisors | - | - | - | Detail |
| SDIC Fund Management | - | - | - | Detail |
| Shangbay Capital | - | - | - | Detail |
| Sherpa Venture Capital | - | - | - | Detail |
| Yanchuang Capital | - | - | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Apr 24, 2017 | Series A | $ 25M | 3E Bioventures,Decheng Capital,etc. | Detail |
| Jun 5, 2019 | Series B | $ 74M | SDIC Fund Management,Sherpa Venture Capital,etc. | Detail |
